NEW YORK (Reuters Health) – Widespread screening of overweight and obese adults for Cushing’s syndrome is not supported by a new study, even when one or more features…
NEW YORK (Reuters Health) – Liquid-based cytology is no better than conventional Pap tests in detecting cervical cancer precursors, according to a report in the Journal of the…
NEW YORK (Reuters Health) – For hypothyroid patients taking levothyroxine, therapeutic levels are best maintained by taking the medication in a fasting state, at least an hour before…
NEW YORK (Reuters Health) – Both low and high levels of adiponectin are associated with an increased risk of death in patients with type 2 diabetes, according to…
NEW YORK (Reuters Health) – For patients with a hematocrit nadir of 24%-30% following percutaneous coronary intervention (PCI), the benefits of blood transfusion are unlikely to outweigh the…
NEW YORK (Reuters Health) – Elevated levels of high-sensitivity C-reactive protein (hsCRP), an inflammatory marker, predicted mortality and myocardial infarction but not stroke in a multiethnic cohort. “Our…
NEW YORK (Reuters Health) – Neoadjuvant treatment with erlotinib (Tarceva), an epidermal growth factor receptor (EGFR) inhibitor, can help downstage bladder cancer to organ-confined disease, thereby increasing the…
NEW YORK (Reuters Health) – Elevated pre-operative blood levels of brain natriuretic peptide (BNP) or N-terminal-proBNP identify patients who are at increased risk for cardiovascular events within 30…
NEW YORK (Reuters Health) – For now at least, the U.S. Preventive Services Task Force (USPSTF) does not recommend that nontraditional risk factors for coronary heart disease be…
NEW YORK (Reuters Health) – For diagnosing heart failure-related pleural effusions, pleural fluid levels of N-terminal pro-brain natriuretic peptide (NT-pro-BNP) are more accurate than BNP levels, say researchers…
